c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells

FASEB J. 1999 Nov;13(14):1939-49. doi: 10.1096/fasebj.13.14.1939.

Abstract

Separate mechanisms for oncogenesis and metastasis have been postulated. We show here that prolonged and invasive cell migration, a key mechanism in cancer metastasis, is linked to c-erbB-2 signaling. Cell lines with c-erbB-2 and EGFR expression and transphosphorylation activity display a high transendothelial invasiveness in an endothelial-extracellular matrix model mimicking a capillary vessel wall in vitro. Tyrosine-phosphorylated c-erbB-2 receptors and EGFR are localized predominantly in areas of the cell with high membrane extension activity. On the molecular level, there is a subtle cross talk between the transmembrane signaling molecule c-erbB-2 and the actin cytoskeleton at multiple levels, including the generation of the second messenger PIP2 and the mobilization of the actin-regulatory protein gelsolin. Our data strongly suggest that c-erbB-2, especially in a heterodimer with EGFR, is closely involved in signaling pathways, inducing alterations in cell morphology that are required for a human breast cancer cell to become motile and conceivably metastatic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / pathology*
  • Cell Division
  • Cell Line
  • Dimerization
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / chemistry
  • ErbB Receptors / physiology
  • Extracellular Matrix / metabolism
  • Female
  • Gelsolin / metabolism
  • Humans
  • Neoplasm Invasiveness
  • Phenotype
  • Phosphorylation
  • Receptor, ErbB-2 / chemistry
  • Receptor, ErbB-2 / physiology*

Substances

  • Gelsolin
  • Epidermal Growth Factor
  • ErbB Receptors
  • Receptor, ErbB-2